Pharmaceuticals 2020, 13, 89.

Exploring kinase inhibition properties of 9H-pyrimido[5,4-b]- and [4,5-b]indol-4-amine derivatives.

Eur. J. Med. Chem. 2015, 92, 124-134.

Synthesis and molecular modelling studies of 8-arylpyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amines as multitarget Ser/Thr kinases inhibitors.

Bioorg. Med. Chem. Lett. 2014, 24, 5037-5040.

Synthesis of new pyridazino[4,5-b]indol-4-ones and pyridazin-3(2H)-one analogs as DYRK1A inhibitors.

Bioorg. Med. Chem. Lett. 2013, 23, 6784-6788.

Synthesis of novel 7-substituted pyrido[2',3':4,5]furo[3,2-d]pyrimidin-4-amines and their N-aryl analogues and evaluation of their inhibitory activity against Ser/Thr Kinases.

Eur. J. Med. Chem. 2013, 59, 283-295.

Synthesis and biological evaluation of N-aryl-7-methoxybenzo[b]furo[3,2-d]pyrimidin-4-amines and their N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases.

 Eur. J. Med. Chem., 2012, 58, 543-556. 

Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents.

Eur. J. Med. Chem., 2012, 58, 171-183.

Synthesis and biological evaluation of N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitors.

J. Med. Chem., 2012, 57, 225-233.

Synthesis and biological evaluation of new 5-benzylated 4-oxo-3,4-dihydro-5H-pyridazino[4,5-b]indoles as PI3K inhibitors. Eur.

Bioorg. Med. Chem. 2008, 16(9), 4932-4953.

Synthesis of 3,5-bis(2-indolyl)pyridine and 3-[(2-indolyl)-5-phenyl]pyridine derivatives as CDK inhibitors and cytotoxic agents.

Eur. J. Med. Chem., 2008, 43(7), 1469-1477.

Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1) / glycogen synthase kinase-3 (GSK-3) inhibitors: synthesis, biological evaluation and molecular modeling studies.

Bioorg. Med. Chem. Lett. 2006, 16, 3419-3423.

Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3.